Literature DB >> 19725890

Pulmonary dysfunction and hepatopulmonary syndrome in cirrhosis and portal hypertension.

Søren Møller1, Aleksander Krag, Jan L Madsen, Jens H Henriksen, Flemming Bendtsen.   

Abstract

BACKGROUND: Pulmonary dysfunction including the hepatopulmonary syndrome (HPS) is an important complication to cirrhosis and portal hypertension. However, the precise relation to liver dysfunction and the prevalence of HPS are unclear. AIMS: We therefore aimed to assess (i) the prevalence of HPS in consecutive alcoholic cirrhotic patients, (ii) the degree of pulmonary dysfunction in relation to liver function and (iii) the response of a 100% oxygen test on cardiopulmonary and peripheral oxygenation.
METHODS: Fifty patients with cirrhosis and 12 matched healthy controls were entered in this study. All underwent haemodynamic and pulmonary investigations [lung diffusing capacity for carbon monoxide (DLCO), contrast-enhanced echocardiography and detection of extrapulmonary shunt fraction]. A 100% oxygen test was performed with the assessment of arterial oxygen tension (PaO(2)), the alveolar-arterial oxygen gradient (AaPO(2)) and peripheral transcutaneous oxygen tension (tcPO(2)).
RESULTS: The prevalence of HPS was 10%. PaO(2) and DLCO were reduced in 32 and 72% and AaPO(2), was increased in 60% of the patients respectively. DLCO correlated with indicators of liver dysfunction (galactose elimination capacity, P<0.01, indocyanine green clearance, P<0.001), portal hypertension (post-sinusoidal resistance, P<0.01) and central hypovolaemia (central and arterial blood volume, P<0.01). After 100% oxygen inhalation, the changes in PaO(2), AaPO(2), tcPO(2) and heart rate were abnormal in the patients compared with controls (P<0.02).
CONCLUSIONS: Pulmonary dysfunction in alcoholic cirrhosis is common and relates to different aspects of liver dysfunction, whereas the prevalence of HPS is low. The haemodynamic response to oxygen inhalation is clearly impaired and HPS and pulmonary dysfunction seem to be caused by different pathophysiological mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19725890     DOI: 10.1111/j.1478-3231.2009.02103.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  10 in total

Review 1.  Differential diagnosis of hepatopulmonary syndrome (HPS): Portopulmonary hypertension (PPH) and hereditary hemorrhagic telangiectasia (HHT).

Authors:  Inna Krynytska; Mariya Marushchak; Anna Mikolenko; Anzhela Bob; Iryna Smachylo; Ludmyla Radetska; Olga Sopel
Journal:  Bosn J Basic Med Sci       Date:  2017-11-20       Impact factor: 3.363

Review 2.  Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects.

Authors:  Søren Møller; Jens H Henriksen; Flemming Bendtsen
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 3.  Cirrhotic Multiorgan Syndrome.

Authors:  Søren Møller; Flemming Bendtsen
Journal:  Dig Dis Sci       Date:  2015-06-26       Impact factor: 3.199

Review 4.  Hepatopulmonary syndrome: update on pathogenesis and clinical features.

Authors:  Junlan Zhang; Michael B Fallon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

5.  Hepatopulmonary syndrome: the role of intra-abdominal hypertension and a novel mouse model.

Authors:  Zhaojie Zhang; Xiaolong Qi; Zhiwei Li; Lijun Xu; Fei Wang; Shenglan Wang; Yizhong Chang; Wanrong Ma; Mingxin Xu; Changqing Yang
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

6.  Pentoxifylline in hepatopulmonary syndrome.

Authors:  Hamid Reza Kianifar; Maryam Khalesi; Eftekhar Mahmoodi; Monavar Afzal Aghaei
Journal:  World J Gastroenterol       Date:  2012-09-21       Impact factor: 5.742

Review 7.  Cirrhosis and its complications: evidence based treatment.

Authors:  Salman Nusrat; Muhammad S Khan; Javid Fazili; Mohammad F Madhoun
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

Review 8.  Diastolic dysfunction in cirrhosis.

Authors:  Søren Møller; Signe Wiese; Hanne Halgreen; Jens D Hove
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

9.  Cardiac function in patients with early cirrhosis during maximal beta-adrenergic drive: a dobutamine stress study.

Authors:  Aleksander Krag; Flemming Bendtsen; Emilie Kristine Dahl; Andreas Kjær; Claus Leth Petersen; Søren Møller
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

10.  Pulse oximeter oxygen saturation in prediction of arterial oxygen saturation in liver transplant candidates.

Authors:  Seiyed Mohammad Ali Ghayumi; Abolfazl Khalafi-Nezhad; Zahra Jowkar
Journal:  Hepat Mon       Date:  2014-04-07       Impact factor: 0.660

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.